propafenone has been researched along with Chronic Kidney Diseases in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceynowa-Sielawko, B | 1 |
| Wybraniec, MT | 1 |
| Topp-Zielińska, A | 1 |
| Maciąg, A | 1 |
| Miśkowiec, D | 1 |
| Balsam, P | 1 |
| Wójcik, M | 1 |
| Wróbel, W | 1 |
| Farkowski, MM | 1 |
| Ćwiek-Rębowska, E | 1 |
| Ozierański, K | 1 |
| Błaszczyk, R | 1 |
| Bula, K | 1 |
| Dembowski, T | 1 |
| Peller, M | 1 |
| Krzowski, B | 1 |
| Wańha, W | 1 |
| Koziński, M | 1 |
| Kasprzak, JD | 1 |
| Szwed, H | 1 |
| Mizia-Stec, K | 1 |
| Szołkiewicz, M | 1 |
1 other study available for propafenone and Chronic Kidney Diseases
| Article | Year |
|---|---|
Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study.
Topics: Amiodarone; Antazoline; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; | 2022 |